Aktieanalys

Nanologica: Delivery for full-scale production - Redeye

Redeye Publicerad: 17 Oct 2023 10:22

Today, Nanologica announced that it has successfully fulfilled an order placed last year for the evaluation of full-scale production by an insulin manufacturer in Asia. The customer is described as "one of the world's largest insulin manufacturers." We see this as a concrete step forward for Nanologica, and consider today's share price surge justified. Later today, we will be recording an interview with the CEO, Andreas Bhagwani, to delve deeper into this exciting news.

Länk till analysen i sin helhet: https://www.redeye.se/research/947383/nanologica-delivery-for-full-scale-production?utm_source=finwire&utm_medium=RSS

Nyheter om Nanologica

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!